Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitors
- 31 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 55 (9), 677-683
- https://doi.org/10.1016/0024-3205(94)00674-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in RatsPharmaceutical Research, 1993
- Improvement of Intestinal Absorption of Thyrotropin-releasing Hormone by Chemical Modification with Lauric AcidJournal of Pharmacy and Pharmacology, 1992
- Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in RatsJournal of Pharmacy and Pharmacology, 1992
- Effect of pH, Dietary Proteins and Trypsin Inhibitors on the Hydrolytic Rate of Human Granulocyte Colony-Stimulating Factor (G-CSF) by Rat Digestive Enzymes.Journal of Pharmacobio-Dynamics, 1991
- Lipophilic Peptides: Synthesis of Lauroyl Thyrotropin-Releasing Hormone and Its Biological ActivityPharmaceutical Research, 1991
- Degradation of Insulin by Trypsin and Alpha-ChymotrypsinPharmaceutical Research, 1991
- Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: Implications in peptide delivery from nonoral routesLife Sciences, 1990
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989
- Neurochemical effects of the synthetic ACTH4–9-analog Hoe 427 (Ebiratide) in rat brainPeptides, 1988
- Learning and memory processes of an ACTH4–9 analog (ebiratide; Hoe 427) in mice and ratsPeptides, 1988